Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutrition

Mary Feeney1, George Du Toit1, Graham Roberts2

  • 1Department of Pediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London and Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.

Insights

Introducing peanut early is feasible for high-risk infants and does not negatively impact growth or nutrition. This strategy effectively prevents peanut allergy without altering breastfeeding duration.

Area of Science:

  • Allergy and Immunology
  • Pediatric Nutrition
  • Clinical Trials

Background:

  • Early peanut introduction is a proven peanut allergy prevention strategy for high-risk infants.
  • However, its feasibility and impact on infant growth and nutrition remain unclear.

Purpose of the Study:

  • To assess the feasibility of introducing peanut products in infancy.
  • To explore the effects of early peanut consumption on infant growth and nutritional intake up to 60 months.

Main Methods:

  • The study involved 640 atopic infants (4-11 months) randomly assigned to consume (6g/week) or avoid peanut until 60 months.
  • Peanut intake, feeding practices, dietary intake (food diaries), and anthropometry were monitored.

Main Results:

  • Peanut consumption was feasible and sustained, with median intake of 7.5g/week in the consumption group.
  • No significant differences in growth, energy intake, or breastfeeding duration were observed between groups.
  • Dietary differences emerged: peanut consumers had higher fat intake, while avoiders had higher carbohydrate intake.

Conclusions:

  • Early peanut introduction is feasible for high-risk infants, showing no adverse effects on breastfeeding, growth, or overall nutrition.
  • Infants achieved energy balance through compensatory fat and carbohydrate intake adjustments.
  • This supports early peanut consumption as a safe and effective allergy prevention strategy.
Abstract